Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors

NCT01158118 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Leukemia, Myeloid, Acute
Myelodysplastic Syndromes
Lymphoma, Non-Hodgkin
Hodgkin Disease
Leukemia, Lymphocytic, Chronic, B-Cell
Multiple Myeloma

Interventions

DRUG: Sargramostim
DRUG: Plerixafor

Sponsor

Washington University School of Medicine